Daniel Wintner Goodman - 25 May 2021 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role
Director
Signature
/s/ Jessica Morris, Attorney-in-Fact
Issuer symbol
TNXP
Transactions as of
25 May 2021
Transactions value $
$5,600
Form type
4
Filing time
26 May 2021, 09:07:43 UTC
Previous filing
12 May 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNXP Common Stock Purchase $5,600 +5,000 +500,000% $1.12 5,001 25 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.